Compound tirzepatide is pharmacy-made tirzepatide, not an FDA-approved drug. See how it compares to Mounjaro and Zepbound, plus safety, cost, and legal status.
Compound tirzepatide is tirzepatide that a licensed compounding pharmacy prepares itself instead of the version Eli Lilly sells as Mounjaro or Zepbound. It is not FDA-approved, and since early 2025 the FDA has stopped allowing large compounding operations to make it as a routine copy of the brand-name drug.
What Is Compound Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. The FDA approved it as Mounjaro for type 2 diabetes in 2022 and as Zepbound for chronic weight management in 2023.
Compounding is the practice of a pharmacy preparing a custom medication for a specific patient, such as when someone cannot tolerate an ingredient in the commercial product. The active molecule may be identical, but the finished vial is mixed, tested, and labeled by the pharmacy rather than by the manufacturer.
People usually look into a tirzepatide compound for a handful of practical reasons:
- Cost: brand-name tirzepatide can exceed $1,000 per month without insurance.
- Access: telehealth platforms made compounded versions easy to order during the 2023–2024 shortage.
- Flexibility: some pharmacies offered different concentrations or added vitamin B12.
Each of those advantages came with a trade-off. The FDA does not review the safety, purity, or potency of a compounded finished product.
Compounded vs. Brand-Name Tirzepatide
The two products share an active ingredient but differ in nearly everything else that affects quality control.
| Feature | FDA-approved tirzepatide | Compounded tirzepatide |
|---|---|---|
| FDA approval | Yes — Mounjaro and Zepbound | No |
| Made by | Eli Lilly | A state-licensed compounding pharmacy |
| Strength consistency | Fixed and label-verified | Varies by pharmacy and batch |
| Independent lab testing | Required by FDA | Not required; ask for a certificate of analysis |
| Typical monthly cost | $1,000+ list price; savings programs may reduce it | Often $200–$500, varies widely |
| Legal status in 2025 | Available by prescription | Limited; mass copying no longer allowed |
Is Compound Tirzepatide Still Legal in the US?
Federal law generally prohibits compounding a drug that is "essentially a copy" of an FDA-approved product that is already commercially available. During the shortage, the FDA used enforcement discretion and looked the other way.
That changed. The FDA determined the tirzepatide shortage was resolved in late 2024 and closed its enforcement windows on February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities.
A state-licensed pharmacy can still compound tirzepatide in narrow, documented situations, such as a verified allergy to an excipient in Zepbound. Mass-marketed compound tirzepatide sold to anyone who completes an online form is a different situation entirely.
Compounded tirzepatide is not FDA-approved for any use, and no compounding pharmacy can guarantee a product identical to Mounjaro or Zepbound.
Is Compound Tirzepatide Safe?
The question many shoppers type — is compound tirzepatide safe — has no single answer, because safety depends on the specific pharmacy, the specific batch, and how the product is handled.
- Potency errors: testing has found vials containing more or less drug than the label states.
- Sterility problems: improper handling can cause injection-site infections and bloodstream infections.
- Dosing mistakes: multi-dose vials and unfamiliar units (milligrams versus "units" on a syringe) lead to overdoses.
- Unknown additives: vitamin B12, niacinamide, and other ingredients change the product.
Side effects of tirzepatide itself are well documented. Nausea, vomiting, diarrhea, constipation, fatigue, and injection-site reactions are common. Rare but serious risks include pancreatitis, gallbladder disease, gastroparesis, and low blood sugar when combined with insulin or sulfonylureas.
Anecdotes are not evidence. Threads on compound tirzepatide reddit mix genuine experiences with products of unknown origin and unknown concentration, so they cannot tell you whether your own vial is safe.
Dosing Basics
Brand-name tirzepatide follows a standard step-up schedule. Doses increase no more often than every four weeks to limit gastrointestinal side effects.
| Weeks | Typical labeled dose |
|---|---|
| 1–4 | 2.5 mg once weekly |
| 5–8 | 5 mg once weekly |
| 9–12 | 7.5 mg once weekly |
| 13–16 | 10 mg once weekly |
| 17–20 | 12.5 mg once weekly |
| 21 and beyond | 15 mg once weekly (maximum) |
Your prescriber decides your actual schedule. Compounded versions sometimes used different concentration labels, which is one reason people report confusing results.
If you are wondering why am i not losing weight on tirzepatide compound, the common explanations are an underdosed vial, a dose that is still too low, a shorter timeline than expected, or a product that is not what the label claims.
How to Evaluate a Tirzepatide Compounding Pharmacy
Search results for the best compounding pharmacy for tirzepatide are often affiliate lists rather than verified information. Use these checks instead.
- Confirm the pharmacy's state license and whether it operates as a 503A or 503B facility.
- Ask for a certificate of analysis from an independent lab for your specific batch.
- Confirm sterility testing and compliance with USP standards for sterile compounding.
- Ask whether a pharmacist will speak with you or your prescriber directly.
- Avoid anything labeled "for research use only" or sold as a powder.
Gray-Market Powders and DIY Mixing
Some online sellers ship lyophilized tirzepatide powder with instructions to reconstitute it at home. Searches such as how much bac water to reconstitute 20mg tirzepatide are a warning sign rather than a how-to.
Those products are not prepared in a licensed pharmacy, carry no sterility guarantee, and put dosing math in the hands of someone without clinical training. Experimental pairings like cagrilintide with tirzepatide are unapproved, largely unstudied in combination, and add another layer of risk.
Questions to Ask Your Prescriber
- Is an FDA-approved tirzepatide product an option for me, and would a savings program lower the cost?
- If a compounded product is being considered, which pharmacy makes it and what testing does it provide?
- What dose am I starting at, and how will we monitor side effects?
- What warning signs mean I should stop the medication and call you?
Compounded medications are not automatically unsafe, and brand-name drugs are not automatically the right fit for everyone. The honest position is that compounded tirzepatide carries extra uncertainty that only a licensed prescriber and a verifiable pharmacy can help you weigh.
Frequently Asked Questions
Is compounded tirzepatide the same as Mounjaro or Zepbound?
It contains the same active molecule, but it is not the same product. Compounded tirzepatide is not FDA-approved, and its strength, purity, and sterility depend on the individual pharmacy rather than on Eli Lilly's manufacturing and testing standards.
Can you still get compounded tirzepatide in the US?
Large-scale compounding of tirzepatide is no longer permitted because the FDA considers the shortage resolved and ended its enforcement discretion in early 2025. A state-licensed pharmacy may still compound it in limited, documented cases, such as a verified allergy to an ingredient in the brand-name product.
How much does compounded tirzepatide cost?
During the shortage, compounded tirzepatide commonly cost roughly $200 to $500 per month, well below the $1,000-plus list price of brand-name tirzepatide. Pricing varies by pharmacy and dose, and insurance rarely covers compounded versions.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.